Health Products

Teva-Ramipril (2.5 mg and 5 mg)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
35328356BB. Teva-Ramipril 5 mg
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
CapsuleDIN 022479465 mg
35328352BA. Teva-Ramipril 2.5 mg
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
CapsuleDIN 022479452.5 mg

Introduction

Recalled Products
  1. Teva-Ramipril (2.5 mg)
  2. Teva-Ramipril (5mg)

Reason

Product stability testing shows that the lot will likely have results above its specification limit for the total impurities test before the labelled expiry date.

Depth of distribution

Lot was distributed to wholesalers and retailers in NF, QC, ON, MB, BC.
Lot was also distributed to compassionate drug programs in ON.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime